Chinese Medical Robot Developer TMiRob Completes Series B+ Round

Chinese medical robot developer TMiRob announced on Tuesday that it has completed a series B+ round of financing in the first quarter of 2019 from several investment units of Spinnotec, a state-owned venture capital platform in Shanghai.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

LEAVE A REPLY